
A PDF of the presentation will be made available on the Company’s website at investors.tristel.com/invest…

Financial PR and IR for smallcap and AIM companies

A PDF of the presentation will be made available on the Company’s website at investors.tristel.com/invest…

✅A good turn out for @TristelGlobal (AIM: #TSTL) CEO Chris Lee and CFO Anna Wasyl presenting at Mello Events London today. Anna and Chris presented the Company's investment case and outlook, and fielded questions from investors.

Investor Presentation 3.00pm GMT Thursday 26 November The presentation will be hosted through the digital platform Investor Meet Company and is open to all investors. 🔗To register, please sign up here: investormeetcompany.com/pci-… Read the RNS here: londonstockexchange.com/en/n…


A PDF of the presentation will be made available on the Company’s website at vericidx.com/investors/

A great turn out for @VericiDx Plc (AIM: #VRCI) at #MelloEvents today. Sara Barrington, CEO provided an overview of the Company and strategy following the recent successful fundraise.

🔗A PDF of the presentation will be made available on the Company’s website ⬇️ inspirationhealthcaregroup.c…

Another successful event for @InspHealthcare (AIM: #IHC) at @MelloEventsUK today. Alan Olby, CFO, presented on the Company's investment case and strategy.

Following the Company's recent Trading Update highlighting strong commercial momentum, James and Mufti took the opportunity to connect with investors, share insights and address their questions. Read the Trading Update here: londonstockexchange.com/en/n…



⬆️Continues to secure orders from new and existing customers, including universities, a technology company and a university-industry collaboration network ✅The Board is confident the business will continue to trade in-line with management expectations for the remainder of 2026

📈The full commercial launch of the subscription-based Invention Evaluation Platform remains on track for December 2026


🇪🇺EU-wide authorisation of Ecovelex is progressing well with recent entry into one of the final review stages

👍Repeated grants reflect continued grower demand for a biological alternative to conventional bird-repellent seed treatments 📈Temporary use has previously led to authorisation of Eden products including Cedroz™ in May 2021